Sellas Life Sciences Group I

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$8.05

+0.29 (+3.74%)

As of Jun 21, 10:20 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 5 83%

Hold 1 17%

Sell 0 0%

Price Target

Analyst Price Target +321.1% upside

Low Target $25.20

Average Target $33.90

High Target $43.49

Current Price $8.05

Current
$8.05

Target
$33.90

$25.20 $33.90 avg $43.49

Scenario Analysis

Bear Case

$25.20

213.0%

Low target

Base Case

$33.90

+321.1%

Avg target

Bull Case

$43.49

+440.2%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$9.51

-15.4% from high

52-Week Low

$1.39

+479.1% from low

Target vs 52W High

$33.90

+256.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%